Huifeng Bio-Pharmaceutical Technology, specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives in China, has announced the appointment of Ms. Amy Xue to Senior Vice President of Finance.
"We are truly delighted that Ms. Xue will be a part of the Company," said Jing'an Wang, Founder, Chairman, and Chief Executive Officer of Huifeng. "Her appointment is an important step in strengthening the Company's internal controls over financial reporting. Ms. Xue brings a tremendous amount of knowledge and strategic counsel to our senior management team and we are fully confident that she will play an integral role in the achievement of Huifeng's growth and financial goals."
Ms. Xue has extensive experience in U.S. GAAP financial reporting and public accounting, and she has performed audit and accounting services for companies in a variety of industries. In 2010, she founded Farolfi & Company, a New York based accounting and business advisory firm. Prior to that, Ms. Xue was a senior manager of Acquavella, Chiarelli, Shuster, Berkower, a public accounting firm in New York that focuses on SEC audits with Chinese companies.